Association of polymorphism of methylene-tetrahydro-folate-reductase with urinary albumin excretion rate in type 1 diabetes mellitus but not with preeclampsia, retinopathy, and preterm delivery

Acta Obstetricia et Gynecologica Scandinavica

Volumn 80, Issue 9, 2001, Pages 803-806

  Lauszus, F F ^a   Gron P L ^a   Klebe, J G ^a  

^a HOLSTEBRO HOSPITAL   (Denmark)

Author keywords

Diabetic pregnancy; Genetic setting; Polymorphism; Risk factors

Indexed keywords

5,10 METHYLENETETRAHYDROFOLATE REDUCTASE (FADH2); ALBUMIN;

ARTICLE; CONTROLLED STUDY; DIABETIC ANGIOPATHY; DIABETIC RETINOPATHY; ENDOTHELIUM CELL; FEMALE; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC RISK; HETEROZYGOTE DETECTION; HOMOZYGOTE; HUMAN; HYPERHOMOCYSTEINEMIA; INSULIN DEPENDENT DIABETES MELLITUS; MAJOR CLINICAL STUDY; MICROANGIOPATHY; PREECLAMPSIA; PREGNANCY DIABETES MELLITUS; PREMATURE LABOR; PREVALENCE; PRIORITY JOURNAL; PROTEINURIA; RISK FACTOR; URINARY EXCRETION; VASCULAR ENDOTHELIUM;

ALBUMINURIA; DIABETES MELLITUS, TYPE 1; DIABETIC RETINOPATHY; FEMALE; HETEROZYGOTE; HOMOZYGOTE; HUMANS; METHYLENETETRAHYDROFOLATE REDUCTASE (NADPH2); OBSTETRIC LABOR, PREMATURE; OXIDOREDUCTASES ACTING ON CH-NH GROUP DONORS; POLYMORPHISM, GENETIC; PRE-ECLAMPSIA; PREGNANCY; PREGNANCY IN DIABETICS; RETROSPECTIVE STUDIES; RISK FACTORS;

EID: 0034854445     PISSN: 00016349     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1600-0412.2001.080009803.x     Document Type: Article

References (15)

1. Hyperhomocysteinemia and endothelial dysfunction in IDDM
2. Plasma homocysteine is related to albumin excretion rate in patients with diabetes mellitus: A new link between diabetic nephropathy and cardiovascular disease?
3. Increased levels of plasma homocysteine are associated with nephropathy, but not severe retinopathy in type 1 diabetes mellitus
4. Plasma homocysteine concentration is increased in preeclampsia and is associated with evidence of endothelial activation
5. Underlying disorders associated with severe early-onset preeclampsia
6. Homocysteine and vascular disease
7. Effects of folic acid and vitamin B6 supplementation on women with hyperhomocysteinemia and a history of preeclampsia or fetal growth restriction
8. A candidate genetic risk factor for vascular disease: A common mutation in methylenetetrahydrofolate reductase
9. Methylene tetrahydrofolate reductase polymorphism and pre-eclampsia
10. Molecular genetic diagnosis of sickle cell disease using dried blood specimens on blotters used for newborn screening
11. Thrombophilic predisposition in stroke and venous thromboembolism in Danish patients
12. Poor metabolic control, early age at onset, and marginal folate deficiency are associated with increasing levels of plasma homocysteine in insulin-dependent diabetes mellitus. A five-year follow-up study
13. The mutation Ala677 → Val in the methylene tetrahydrofolate reductase gene: A risk factor for arterial disease and venous thrombosis
14. A common mutation in the methylenetetra-hydrofolate reductase gene (C677T) increases the risk for deep-vein thrombosis in patients with mutant factor V (Factor V:Q (506))
15. Changes in homocysteine levels during normal pregnancy